Drug
Vivitrol clinical trials
- studies test it
- 37
- open now
- 0
- in phase 3
- 15
- first study started
- 2002
How studies write it
Studies that test it under each name
Studies by the year they started
37 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 10
- Phase 3
- 15
- Phase 4
- 12
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 26
Alkermes, Inc. (11) · University of Pennsylvania (4) · New York State Psychiatric Institute (3) · NYU Langone Health (3) · Oregon Health and Science University (2) · Yale University (2) · National Institute on Drug Abuse (NIDA) (1) · Lars Tanum (1)
Often tested with
Tested in the same studies.
Buprenorphine (5) · Naltrexone (3) · Naloxone (2) · Bupropion (1) · Bupropion Hydrochloride Controlled-release (1) · Methadone (1)
Studies
Open first, then newest update. How each study uses vivitrol is read from its arms, and is right about nine times in ten.
Testing it · 37
- Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use DisorderActive, not recruitingPhase 3National Institute on Drug Abuse (NIDA)NCT06233799Written as extended-release naltrexone (XR-NTX)
- Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1TerminatedPhase 2University of PennsylvaniaNCT04480554Written as XR-Naltrexone
- CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and RecoveryCompletedPhase 2University of PennsylvaniaNCT01587196Written as Vivitrol
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSDTerminatedPhase 2Pharmacotherapies for Alcohol and Substance Use Disorders AllianceNCT03852628Written as 2mg Buprenex and 380mg Vivitrol
- Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use DisorderTerminatedPhase 4University of California, San FranciscoNCT04094584Written as Vivitrol (Extended Release Naltrexone)
- Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and RecoveryCompletedPhase 4Lars TanumNCT03647774Written as Extended release naltrexone
- A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine RespondersCompletedPhase 3New York State Psychiatric InstituteNCT03232346Written as Vivitrol
- Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department UsersCompletedPhase 4NYU Langone HealthNCT02445339Written as XR-NTX+CM (Extended-Release Naltrexone plus Care Management)
- Buprenorphine as Adjunct to Outpatient Induction Onto VivitrolTerminatedPhase 2/3New York State Psychiatric InstituteNCT03113409Written as Vivitrol
- Extended Release Naltrexone for Opioid-Dependent YouthCompletedPhase 4Friends Research Institute, Inc.NCT01843023Written as Extended Release Naltrexone
- Alcohol Disorder hOsPital Treatment TrialCompletedPhase 4Boston UniversityNCT02478489Written as Extended-release injectable naltrexone (XR-NTX)
- Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use DisorderCompletedPhase 3University of Texas Southwestern Medical CenterNCT03078075Written as Naltrexone: Vivitrol®
- Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable NaltrexoneCompletedPhase 2/3University of PennsylvaniaNCT02617628Written as extended release naltrexone
- Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary CareCompletedPhase 4NYU Langone HealthNCT01893827Written as XR-NTX (Extended-Release Naltrexone)
- Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court SettingsCompletedPhase 4Duke UniversityNCT02978417Written as Naltrexone for extended-release injectable suspension
- Study of Long-Acting Injectable Naltrexone to Treat Cannabis DependenceCompletedPhase 1/2New York State Psychiatric InstituteNCT02088177Written as Long-acting injectable naltrexone
- Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness StudyCompletedPhase 3Oregon Health and Science UniversityNCT01908062Written as Extended Release Naltrexone
- Risky Decision Making in Methamphetamine Users: The Role of Opioid BlockadeCompletedNot applicableOregon Health and Science UniversityNCT01822132Written as Extended release naltrexone
- ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care ProfessionalsCompletedPhase 3Alkermes, Inc.NCT00834080Written as Medisorb naltrexone 380 mg
- The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid DependenceCompletedPhase 2Johns Hopkins UniversityNCT01556425Written as Vivitrol
See all 37 studies that test vivitrol →
Given in every arm · 2 — vivitrol is usual care beside what is tested
As the comparator · 5 — what is tested is compared with vivitrol
- A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.RecruitingPhase 1Inventage Lab., Inc.NCT05620940Written as Vivitrol Injectable Product
- Brain Mechanisms of Pharmacotherapy in Opioid Use DisorderTerminatedPhase 2University of PennsylvaniaNCT04454411Written as Vivitrol
- Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol InjectionsCompletedPhase 1BioCorRx IncNCT04828694Written as Vivitrol
- Re-entry XR-NTX for Rural Individuals With Opioid Use DisorderCompletedEarly Phase 1Michele StatonNCT03447743Written as XR-NTX community location
- Cocaine Use Reduction With BuprenorphineCompletedPhase 2/3University of California, Los AngelesNCT01402492Written as Placebo + Naltrexone